학술논문

TRAIL-b and TRAIL-?: two novel splice variants of the human TNF-related apoptosis-inducing ligand (TRAIL) without apoptotic potential.
Document Type
Article
Source
British Journal of Cancer. 3/24/2003, Vol. 88 Issue 6, p918. 10p.
Subject
*TUMOR necrosis factors
*TUMORS
*APOPTOSIS
Language
ISSN
0007-0920
Abstract
Tumour necrosis factor (TNF) related apoptosis-inducing ligand (TRAIL/APO2L) is a recently identified member of the TNF family, which induces programmed cell death in a variety of neoplastic cell types, but not in most nonneoplastic cells. In this study, we report on the identification of two novel alternative splice variants of TRAIL in neoplastic and non-neoplastic human cells lacking either exon 3 (TRAIL-β) or exons 2 and 3 (TRAIL-γ). In both splice variants, loss of exon 3 resulted in a frame shift generating a stop codon with consecutive extensive truncation in the extracellular domain. Ectopic expression revealed a loss of proapoptotic potential for both alternative splice variants. In contrast to the predominantly cytoplasmatic localisation of GFP-tagged TRAIL-α and TRAIL-β, TRAIL-γ showed an additional association with the cell surface and nuclear membrane. In conclusion, alternative splicing might be involved in fine tuning of TRAIL-induced apoptosis and underlines the complexity of the TRAIL system. [ABSTRACT FROM AUTHOR]